Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine
Abstract
Interleukin-1β (IL-1β) is a cytokine protein expressed by cardiomyocyte in myocardial damage-associated inflammation. Although several methods are currently available for treatment of heart diseases none of them are completely successful. Recently, stem cells have gained enormous attention and are expected to play a significant role for treating heart diseases. 5-Azacytidine (5-aza) has recently been found to cause stimulation of stem cells to differentiate into cardiomyocytes. Here we present the determination of whether IL-1β can induce the differentiation of mesenchymal stem cells (MSCs) to cardiomyocytes. MSCs were derived from bone marrow, propagated and then cultured in differentiation medium supplemented with 5-aza and IL-1β (at two levels, 5 and 10 ng/ml). After 21 days, total RNA was extracted and cDNA synthesis was carried out. Quantitative polymerase chain reaction (Q-PCR) was performed for detecting cardiac-specific markers. Besides, to investigate the expression of cardiac markers in protein levels, immunocytochemistry was done by specific antibodies. Ultimately, cardiac markers expression suggested that IL-1β and 5-aza synergistically induces the cardiomyocyte differentiation.
Acknowledgments
This study was supported by a grant provided by Golestan University of Medical Sciences, Grgan, Iran. Mahin Solati is currently a MSc student at the Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, and this paper is part of her MSc graduation.
References
Amano, K., Okigaki, M., Adachi, Y., Fujiyama, S., Mori, Y., Kosaki, A., Iwasaka, T., and Matsubara, H. (2004). Mechanism for IL-1b-mediated neovascularization unmasked by IL-1b knock-out mice. J. Mol. Cell. Cardiol. 36, 469–480.10.1016/j.yjmcc.2004.01.006Search in Google Scholar
Antonitsis, P., Ioannidou-Papagiannaki, E., Kaidoglou, A., and Papakonstantinou, C. (2007). In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Inter. Cardio. Thora. Surg. 6, 593–597.10.1510/icvts.2007.157875Search in Google Scholar
Bagchi, A.K., Sharma, A., Dhingra, S., Ludke, A.R., Al-Shudiefat, A.A., and Singal, P.K. (2013). Interleukin-10 activates Toll-like receptor 4 and requires MyD88 for cardiomyocyte survival. Cytokine 61, 304–314.10.1016/j.cyto.2012.10.013Search in Google Scholar
Beltrami, A.P., Urbanek, K., Kajstura, J., Yan, S.M., Finato, N., Bussani, R., Nadal-Ginard, B., Silvestri, F., Leri, A., Beltrami, C.A., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750–1757.10.1056/NEJM200106073442303Search in Google Scholar
Boheler, K.R., Czyz, J., Tweedie, D., Yang, H.T., Anisimov, S.V., and Wobus, A.M. (2002). Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91, 189–201.10.1161/01.RES.0000027865.61704.32Search in Google Scholar
Braunwald, E. and Bristow, M.R. (2000). Congestive heart failure: fifty years of progress. Circulation 102, IV14–IV23.10.1161/01.CIR.102.suppl_4.IV-14Search in Google Scholar
Braunwald, E. and Pfeffer, M. (1991). Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. Am. J. Cardiol. 68, 1–6.10.1016/0002-9149(91)90255-JSearch in Google Scholar
Chang, S.A., Lee, E.J., Kang, H.J., Zhang, S.Y., Kim, J.H., Li, L., Youn, S.W., Lee, C.S., Kim, K.H., Won, J.Y., et al. (2008). Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cell. 26, 1901–1912.10.1634/stemcells.2007-0708Search in Google Scholar
Deans, R.J. and Moseley, A.B. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 28, 875–884.10.1016/S0301-472X(00)00482-3Search in Google Scholar
Jaiswal, R.K., Jaiswal, N., Bruder, S.P., Mbalaviele, G., Marshak, D.R., and Pittenger, M.F. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275, 9645–9652.10.1074/jbc.275.13.9645Search in Google Scholar PubMed
Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41–49.10.1038/nature00870Search in Google Scholar PubMed
Kadivar, M., Khatami, S., Mortazavi, Y., Shokrgozar, M.A., Taghikhani, M., and Soleimani, M. (2006). In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 340, 639–647.10.1016/j.bbrc.2005.12.047Search in Google Scholar PubMed
Kazemnejad, S., Allameh, A., Soleimani, M., Gharehbaghian, A., Mohammadi, Y., Amirizadeh, N., and Jazayeri, M. (2008). Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatible nanofibrous scaffold. Int. J. Artif. Organs. 31, 500–507.10.1177/039139880803100605Search in Google Scholar PubMed
Koudssi, F., Lopez, J., Villegas, S., and Long, S. (1998). Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1b. J. Biol. chem. 273, 25796–25803.10.1074/jbc.273.40.25796Search in Google Scholar PubMed
Koyanagi, M., Haendeler, J., Badorff, C., Brandes, R.P., Hoffmann, J., Pandur, P., Zeiher, A.M., Kühl, M., and Dimmeler, S. (2005). Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J. Biol. Chem. 280, 16838–16842.10.1074/jbc.M500323200Search in Google Scholar PubMed
Leri, A., Kajstura, J., Anversa, P., and Frishman, W.H. (2008). Myocardial regeneration and stem cell repair. Curr. Probl. Cardiol. 33, 91–153.10.1016/j.cpcardiol.2007.11.002Search in Google Scholar PubMed
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L.B., Azarin, S.M., Raval, K.K., Zhang, J., Kamp, T.J., and Palecek, S.P. (2012). Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 109, 1848–1857.10.1073/pnas.1200250109Search in Google Scholar PubMed PubMed Central
Lin, F.H., Chang, J.B., McGuire, M.H., Yee, J.A., and Brigman, B.E. (2010). Biphasic effects of interleukin-1b on osteoblast differentiation in vitro. Orthop. Res. 28, 958–964.10.1002/jor.21099Search in Google Scholar PubMed
Lo, B. and Parham, L. (2009). Ethical issues in stem cell research. Endocr. Rev. 30, 204–213.10.1210/er.2008-0031Search in Google Scholar PubMed PubMed Central
Paige, S., Osugi, T., Afanasiev, O., Pabon, L., Reinecke, H., and Murry, C. (2010). Endogenous Wnt/b-Catenin signaling is required for cardiac differentiation in human embryonic stem cells. PLoS One 5, 11134.10.1371/journal.pone.0011134Search in Google Scholar PubMed PubMed Central
Rangappa, S., Entwistle, J., Wechsler, A.S., and Kresh, Y. (2003). Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J. Thorac. Cardiovasc. Surg. 126, 124–132.10.1016/S0022-5223(03)00074-6Search in Google Scholar
Sekiya, I., Vuoristo, J.T., Larson, B.L., and Prockop, D.J. (2002). In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. USA 99, 4397–4402.10.1073/pnas.052716199Search in Google Scholar PubMed PubMed Central
Sonomoto, K., Yamaoka, K., Oshita, K., Fukuyo, S., Zhang, X., Nakano, K., Okada, Y., and Tanaka, Y. (2012). Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase–like orphan receptor 2 pathway. Arthrit. Rheumat. 64, 3355–3363.10.1002/art.34555Search in Google Scholar PubMed
Thaik, C., Calderone, A., Takahashi, N., and Colucci, W. (1995). lnterleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. PLoS One 96, 1093–1099.10.1172/JCI118095Search in Google Scholar
Ullah, I., Baregundi Subbarao, R., and Jin Rho, G. (2015). Human mesenchymal stem cells – current trends and future prospective. Biosci. Rep. 35, e00191.10.1042/BSR20150025Search in Google Scholar PubMed PubMed Central
Van Tassell, B., Toldo, S., Mezzaroma, E., and Abbate, A. (2013). Targeting interleukin-1 in heart disease. Circulation 128, 1910–1923.10.1161/CIRCULATIONAHA.113.003199Search in Google Scholar PubMed PubMed Central
Xiaojun, L., Jianhua, Z., Samira, M.A., Kexian, Z., Laurie, B.H., Xiaoping, B., Cheston, H., Timothy, J.K., and Sean, P.P. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162–175.10.1038/nprot.2012.150Search in Google Scholar PubMed PubMed Central
Xing, Y., Lv, A., Wang, L., and Yan, X. (2012). The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. Mol. Cell. Biochem. 360, 279–287.10.1007/s11010-011-1067-zSearch in Google Scholar PubMed
Xu, W., Zhang, X., Qian, H., Zhu, W., Sun, X., Hu, J., Zhou, H., and Chen, Y. (2004). Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp. Biol. Med. 229, 623–31.10.1177/153537020422900706Search in Google Scholar PubMed
©2016 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Guest Editorial
- Highlight: remodelling the KLK landscape down under
- HIGHLIGHT: 6TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES
- Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
- Mechanistic insight from murine models of Netherton syndrome
- Development of molecules stimulating the activity of KLK3 – an update
- Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
- Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
- Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
- Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis
- A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
- Therapeutic modulation of tissue kallikrein expression
- In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
- A computational analysis of the genetic and transcript diversity at the kallikrein locus
- Reviews
- Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
- The power, pitfalls and potential of the nanodisc system for NMR-based studies
- Research Articles/Short Communications
- Cell Biology and Signaling
- Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine
Articles in the same Issue
- Frontmatter
- Guest Editorial
- Highlight: remodelling the KLK landscape down under
- HIGHLIGHT: 6TH INTERNATIONAL SYMPOSIUM ON KALLIKREINS AND KALLIKREIN-RELATED PEPTIDASES
- Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications
- Mechanistic insight from murine models of Netherton syndrome
- Development of molecules stimulating the activity of KLK3 – an update
- Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors
- Structural basis for the Zn2+ inhibition of the zymogen-like kallikrein-related peptidase 10
- Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
- Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis
- A viable mouse model for Netherton syndrome based on mosaic inactivation of the Spink5 gene
- Therapeutic modulation of tissue kallikrein expression
- In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B
- A computational analysis of the genetic and transcript diversity at the kallikrein locus
- Reviews
- Lymphocyte signaling and activation by the CARMA1-BCL10-MALT1 signalosome
- The power, pitfalls and potential of the nanodisc system for NMR-based studies
- Research Articles/Short Communications
- Cell Biology and Signaling
- Synergistic induction of cardiomyocyte differentiation from human bone marrow mesenchymal stem cells by interleukin 1β and 5-azacytidine